Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorCabioglu, N.
dc.contributor.authorKaranlik, H.
dc.contributor.authorIgci, A.
dc.contributor.authorUras, C.
dc.contributor.authorDulgeroglu, O.
dc.contributor.authorCakmak, G. Karadeniz
dc.contributor.authorSezer, A.
dc.contributor.authorGurleyik, G.
dc.contributor.authorTukenmez, M.
dc.contributor.authorBademler, S.
dc.contributor.authorMuslumanoglu, M.
dc.contributor.authorOzkurt, E.
dc.contributor.authorYildirim, N.
dc.contributor.authorUgurlu, M. U.
dc.contributor.authorBalbaloglu, H.
dc.contributor.authorEmiroglu, S.
dc.contributor.authorOzmen, V.
dc.contributor.authorGulluoglu, B. M.
dc.date.accessioned2025-10-16T15:12:01Z
dc.date.issued2025
dc.identifier.doi10.1016/j.ejso.2025.109642
dc.identifier.otherWOS:001434558500001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5191
dc.publisherELSEVIER SCI LTD
dc.sourceEJSO
dc.subjectNeoadjuvant systemic treatment
dc.subjectHER2\\-positive breast cancer
dc.subjectTriple\\-negative breast cancer
dc.subjectRecurrence
dc.subjectNode\\-positive breast cancer
dc.titleOmission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS